PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
730.06%
Some net income increase while CRK is negative at -168.47%. John Neff would see a short-term edge over the struggling competitor.
-1.13%
Both reduce yoy D&A, with CRK at -7.82%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-34.93%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-202.47%
Negative yoy working capital usage while CRK is 283.75%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-202.47%
Negative yoy usage while CRK is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-226.23%
Negative yoy while CRK is 1294.54%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-54.38%
Negative yoy CFO while CRK is 50.86%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
3.94%
Some CapEx rise while CRK is negative at -406.74%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
2126.86%
Growth well above CRK's 2707.91%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
145.10%
We have mild expansions while CRK is negative at -6.86%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-1910.91%
We cut debt repayment yoy while CRK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-17.39%
Negative yoy issuance while CRK is 2496.23%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-19.21%
We cut yoy buybacks while CRK is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.